| . In 2008, the Polish pharmaceutical market was 6.9 | | | | PROSPER, TORFARM and ORFE) accounted for 65% |
| billion U.S. dollars, up 11.5%. Which, OTC market was | | | | share of pharmaceutical wholesale market. |
| 2.1 billion U.S. dollars, the Polish OTC market the last | | | | Poland is responsible for drug registration and audit of |
| two years are close to 14% annual growth rate, | | | | the department as a "Polish medicine, Medical Devices |
| faster growth is mainly health care products and | | | | And the Pesticide Registration Board. "After Poland |
| diagnostic reagents; prescription drug market was 4.4 | | | | joined the European Union, according to the |
| billion U.S. dollars, up 10% , which accounted for | | | | regulations, drugs only through the Authority's |
| 47.2% of patent medicines, Generic 52.8%. | | | | approval to use in the European Union. European |
| Pharmaceutical sales in Poland, pharmacies account | | | | Union to Poland 15-year transition period, during this |
| for 80% of the share, the hospital accounted for | | | | period, the Polish health sector should complete all the |
| 15%, 5% other retail outlets. | | | | drugs registration process, now Poland has more than |
| Since the 90's, the Polish pharmaceutical industry | | | | 15,000 kinds of medicines by registered and licensed, |
| from the original privatization of state-owned | | | | there are still more than 8,000 kinds of medicines to |
| monopoly to a comprehensive restructuring, basically | | | | be reviewed. in Poland for drug registration, the |
| completed in 2009. Poland Total current | | | | manufacturer must provide their product safety, |
| Pharmaceutical companies More than 120, including | | | | efficacy and quality of available Control of proof, |
| government-controlled enterprises 3. Poland, the | | | | including pre-clinical research and clinical studies of lab |
| domestic gross domestic pharmaceutical Medicine | | | | reports, medical research must conform to |
| 36.5% of the market. | | | | "non-clinical research pharmaceutical quality control" |
| Polish Ministry of Health convened an expert on | | | | (GCP) and "Good Manufacturing Practices |
| behalf of each year, the Ministry of Finance, | | | | Certification" (GMP) of the requirements. |
| Economy and Labour, social policy and national Health | | | | Poland Drugs Import Large amount, a total of 2008 |
| Insurance Funds in the Working Group, responsible | | | | drugs worth six billion U.S. dollars of imports, mainly |
| for the formulation and review the list of | | | | from Germany, France, Belgium and the UK drugs or |
| reimbursable drugs. In recent years, Poland, the | | | | high-grade Western medicine. But the Polish |
| proportion of state reimbursement of drugs | | | | government has adopted to strengthen supervision |
| continued to decline. | | | | to ensure the market position of domestic |
| Poland there are about 12,000 pharmacies, each | | | | enterprises, in 2006 the Polish government to force |
| pharmacy's monthly average sales of about 5 million | | | | foreign drug price cuts, intended to offset the |
| retail pharmacy chain has become the mainstream of | | | | appreciation of their currencies to bring them |
| development for medicines, pharmacy chain stores | | | | additional profits. 2008, Poland exported drugs worth |
| accounted for 12% of the total. Pharmacy chain was | | | | 1.6 billion U.S. dollars, in addition to some transit trade, |
| increasing year by year trend. At present Poland as a | | | | the other for its own production of ordinary common |
| major pharmacy chain brand L IT UANIAN EURO | | | | Western medicine, the main trade partner of |
| APTEKAH and SUPER-PHARM. | | | | Germany and Russia. By the financial crisis, Poland |
| Poland pharmacies selling drugs from the country | | | | large decline in demand for high-grade drugs, 1 July |
| more than 700 pharmaceutical wholesale enterprises. | | | | 2009, Poland imported medicines worth only 25 billion, |
| Pharmaceutical manufacturers are willing to help | | | | down 31% over the same period, especially from the |
| wholesalers extensive distribution network of | | | | two countries to import drugs decreased nearly |
| professional help improve product sales; retailers need | | | | 40%; and Polish exports of essential drugs commonly |
| a strong logistics system with wholesalers, more | | | | used drugs mainly, so relatively small. |
| quickly and easily purchase a full range, low-priced | | | | 2009 1 ~ 9 months, China exported medical products |
| quality products. In recent years, Poland to learn | | | | worth of Poland for the 95 million U.S. dollars, with |
| Western business models, and gradually realized the | | | | exports accounting for a larger Western raw |
| scale of pharmaceutical wholesale and intensification, | | | | materials, disposable supplies and hospital diagnostic |
| large pharmaceutical wholesalers in the profit model is | | | | and treatment equipment; while China mainly imports |
| no longer the size of margins, but the size of sales. | | | | from Poland medicine raw materials "6? caprolactam", |
| At present, the Polish market as a whole still high | | | | which accounts for our pharmaceutical products |
| drug prices, pharmacies average profit margin over | | | | imported from Poland 90%. |
| 26%, the top five wholesalers (PGF, FARMACOL, | | | | |